PHARMA-TRADE A/S — Credit Rating and Financial Key Figures
CVR number: 87339815
Skaaremosevej 11-14, Blistrup 3230 Græsted
rsa@persano.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 2 884.42 | 62.24 | |||
| Costs of manufacturing | -1 561.71 | -58.69 | |||
| Gross profit | 1 322.71 | 3.55 | |||
| Costs of management | -1 812.06 | -70.40 | -57.92 | -17.97 | -42.22 |
| EBIT | - 489.35 | -66.85 | -57.92 | -17.97 | -42.22 |
| Other financial income | 68.08 | 59.98 | 111.83 | 231.71 | 2 347.29 |
| Other financial expenses | - 108.19 | - 158.85 | -38.08 | -92.15 | -29.59 |
| Net income from associates (fin.) | 30 587.52 | 41 207.46 | 46 427.96 | 27 921.27 | 32 578.67 |
| Pre-tax profit | 30 058.06 | 41 041.74 | 46 443.79 | 28 042.86 | 34 854.16 |
| Income taxes | 116.89 | 36.51 | -3.28 | -28.24 | - 500.43 |
| Net earnings | 30 174.95 | 41 078.25 | 46 440.52 | 28 014.62 | 34 353.72 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 213 022.81 | 219 148.70 | 228 358.25 | 163 915.86 | 175 436.16 |
| Investments total | 213 022.81 | 219 148.70 | 228 358.25 | 163 915.86 | 175 436.16 |
| Non-current loans receivable | 476.43 | 362.65 | 428.98 | 571.95 | 562.93 |
| Long term receivables total | 476.43 | 362.65 | 428.98 | 571.95 | 562.93 |
| Finished products/goods | 86.02 | ||||
| Inventories total | 86.02 | ||||
| Current trade debtors | 51.14 | ||||
| Current amounts owed by group member comp. | 75.77 | 109.26 | 191.32 | 59 701.29 | 61 747.24 |
| Current other receivables | 6.65 | 4.10 | 5.33 | ||
| Current deferred tax assets | 8 237.70 | 12 424.99 | 14 128.69 | 10 802.40 | 8 709.01 |
| Short term receivables total | 8 364.61 | 12 534.25 | 14 326.65 | 70 507.80 | 70 461.58 |
| Cash and bank deposits | 3 136.13 | 2 328.49 | 3 808.83 | 3 108.61 | 4 943.91 |
| Cash and cash equivalents | 3 136.13 | 2 328.49 | 3 808.83 | 3 108.61 | 4 943.91 |
| Balance sheet total (assets) | 225 085.99 | 234 374.10 | 246 922.70 | 238 104.22 | 251 404.58 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 |
| Shares repurchased | 30 000.00 | 40 000.00 | 40 000.00 | 20 000.00 | 30 000.00 |
| Other reserves | 146 428.13 | 164 158.40 | 173 367.95 | 108 925.56 | 120 445.86 |
| Retained earnings | 5 362.52 | -15 020.49 | -20 370.20 | 78 149.04 | 63 585.00 |
| Profit of the financial year | 30 174.95 | 41 078.25 | 46 440.52 | 28 014.62 | 34 353.72 |
| Shareholders equity total | 214 965.60 | 233 216.16 | 242 438.26 | 238 089.22 | 251 384.58 |
| Non-current liabilities total | |||||
| Current trade creditors | 39.44 | 30.00 | 30.00 | 15.00 | 20.00 |
| Current owed to group member | 9 998.48 | 1 119.15 | 4 454.44 | ||
| Other non-interest bearing current liabilities | 82.47 | 8.78 | |||
| Current liabilities total | 10 120.39 | 1 157.93 | 4 484.44 | 15.00 | 20.00 |
| Balance sheet total (liabilities) | 225 085.99 | 234 374.10 | 246 922.70 | 238 104.22 | 251 404.58 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.